STOCK TITAN
  1. Home
  2. News
  3. CCM

Concord Medical Services - CCM STOCK NEWS

Welcome to our dedicated news page for Concord Medical Services (Ticker: CCM), a resource for investors and traders seeking the latest updates and insights on Concord Medical Services.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Concord Medical Services's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Concord Medical Services's position in the market.

News
Concord Medical Files 2023 Annual Report on Form 20-F
Rhea-AI Summary
Concord Medical Services Holdings (NYSE: CCM) filed its 2023 Annual Report on Form 20-F, showcasing its performance in cancer treatment, research, education, and prevention in China. Shareholders can access the report electronically or request a hard copy for free.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price
Rhea-AI Summary
Concord Medical Services Holdings Limited (NYSE: CCM) received a letter from the NYSE stating non-compliance due to low trading price of ADSs. The company has until August 12, 2024, to raise the price above $1.00 to regain compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited
Rhea-AI Summary
Concord Medical Services Holdings Limited (CCM) announced the listing of a minority stake of 39,420,200 H shares in Concord Healthcare Group Co., Ltd. at an initial public offer price of HK$14.28 per H share on the Main Board of The Stock Exchange of Hong Kong Limited. The gross proceeds from the initial public offering of Concord Healthcare on the HKSE are HK$562.9 million (approximately US$72.2 million).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Concord Medical Schedules 2023 Annual Meeting of Shareholders
Rhea-AI Summary
Concord Medical Services Holdings Limited (NYSE: CCM) to hold its 2023 annual general meeting of shareholders on December 26, 2023, at 10:00 a.m. (Beijing Time). The meeting will be held at Room 26A1-26A5, East Tower, Hanwei Building, No. 7 Guanghua Road, Chaoyang District, Beijing, China. Shareholder record date is November 27, 2023. No proposal will be submitted for shareholder approval. Instead, the Meeting will be convened for shareholders who are entitled to vote to discuss Company affairs with management. Concord Medical's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission is available on the Company's website and the SEC's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
-
News
Concord Medical Reports Financial Results for the First Half of 2023
Rhea-AI Summary
Concord Medical Services Holdings announces 97.2% increase in total net revenues for the first half of 2023, reaching RMB284.5 million ($39.2 million). Gross loss decreases to RMB37.4 million ($5.2 million) compared to RMB88.7 million last year. Net loss attributable to ordinary shareholders is RMB91.0 million ($12.5 million). Non-GAAP net loss is RMB210.3 million ($29.0 million). Adjusted EBITDA is negative RMB148.4 million ($20.5 million).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Concord Medical Files 2022 Annual Report on Form 20-F
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
none
News
Concord Medical Schedules 2022 Annual Meeting of Shareholders
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Concord Medical Announces the Successful Holding of the Second Annual Academic Meeting with the world well-known MD Anderson
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
Concord Medical Announces Changes in Management
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News
Concord Medical Reports Financial Results for the First Half of 2022
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Stock CCM logo
Concord Medical Services

NYSE:CCM

CCM Rankings

#5037 Ranked by Market Cap
#2919 Ranked by Stock Gains
N/A Ranked by Dividends

CCM Stock Data

27.35M
42.28M
18%
0.19%
0.03%
Dental Laboratories
Manufacturing
Link
China
Beijing

About CCM

concord medical services holdings limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the people's republic of china. the company operates in network and hospital segments. the company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. it also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. in addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical resear